Active Ingredient(s): Sodium Ferric Gluconate Complex
FDA Approved: * February 18, 1999
Pharm Company: * WATSON PHARMS
Category: Anemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Ferrlecit Overview

Sodium ferric gluconate complex, sold under the brand name Ferrlecit, is an intravenously administered iron medication for the treatment of iron deficiency anemia in adults and in children aged six years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy.[2] The macromolecule has an apparent molecular weight of 289,000 – 440,000 Dalton.[3] The most common side effects in adults are nausea, vomiting ...

Read more Ferrlecit Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sodium_ferric_gluconate_complex

Recent Ferrlecit Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sodium Ferric Gluconate Complex
  • Injection: 12.5mg/ml, 62.5mg/5ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ferrlecit: (3 results)

Sorted by National Drug Code
  • 0024-2791 Ferrlecit 12.5 mg/ml Intravenous Injection by Sanofi-aventis U.S. LLC
  • 0024-2792 Ferrlecit 12.5 mg/ml Intravenous Injection by Sanofi-aventis U.S. LLC
  • 0024-2794 Ferrlecit 12.5 mg/ml Intravenous Injection by Sanofi-aventis U.S. LLC

Other drugs which contain Sodium Ferric Gluconate Complex or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA